|
|
ESTECH Signs Distribution Agreement with NeoprobeESTECH Initiates U.S. Distribution of Quantix Blood Flow Devices that help Cardiac Surgeons improve patient outcomesSan Francisco, CA, June 10, 2006-At the ISMICS (International Society For Minimally Invasive Cardiothoracic Surgery) 9th Annual Scientific Meeting, ESTECH, Inc. of San Ramon, CA, announced it has entered into a U.S. Distribution Agreement with Neoprobe Corporation (OTCBB: NEOP) for the Cardiosconix Quantix/OR blood flow measurement system. The Quantix/OR is designed to provide surgeons with quantitative hemodynamic information in coronary artery bypass graft (CABG) and carotid endarterectomy procedures."This technology represents our continuing goal of providing cardiac surgeons with innovative new technologies for improving patient outcomes when undergoing cardiac surgery procedures", said Ray Bertolero, ESTECH Vice President and co-founder. "The Quantix/OR system compliments our current offerings for cardiovascular surgery in the U.S. market while helping to make cardiac procedures more effective. "The ESTECH agreement provides us with a proven national marketing organization and validates our belief in the blood flow measurement market," said David Bupp, President of Neoprobe. "By joining a leader in servicing the CABG marketplace, the Quantix/OR system will be better positioned to achieve broader market penetration. The strength of ESTECH's product offering will allow us to establish an important presence in the key market for our blood flow products." About ESTECH Headquartered in San Ramon, CA, ESTECH offers tools for least invasive techniques and traditional approaches to the procedures that cardiac surgeons do every day - coronary artery bypass, valve surgery, atrial ablation and surgical treatment of congestive heart failure. About Neoprobe Neoprobe develops and provides innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of healthcare professionals. Neoprobe's products are available throughout the world and are supported by a world-wide servicing capability.
Back to News |
||||||||||||||||